Kaupinen Wes 4/A
4/A · PALVELLA THERAPEUTICS, INC. · Filed Feb 10, 2025
Insider Transaction Report
Form 4/AAmended
Kaupinen Wes
DirectorPresident and CEO10% Owner
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-02-05+243,831→ 243,831 totalExercise: $14.76Exp: 2035-02-05→ Common Stock (243,831 underlying)
Footnotes (1)
- [F1]The stock options will vest in equal monthly tranches over 48 months